Immunocore Holdings Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio4.7613.5415.6841.15
P/B Ratio4.099.168.076.46
Price/Tangible Book4.099.168.076.46
Price/FCF70.66
Price/OCF56.631148.85
Enterprise Value Ratios
EV/Revenue3.4012.1113.9334.05
EV/FCF50.54
Profitability & Returns
Return on Equity (ROE)-0.14%-0.16%-0.18%-1.17%-2.11%
Return on Assets (ROA)-0.04%-0.07%-0.07%-0.32%-0.29%
Return on Invested Capital (ROIC)-4.16%-7.14%
Return on Capital Employed (ROCE)-0.07%-0.13%-0.12%-0.54%-0.63%
Leverage & Solvency Ratios
Debt/Equity1.200.230.240.371.15
Debt/FCF20.72
Liquidity Ratios
Current Ratio4.383.804.704.292.78
Quick Ratio4.263.634.564.172.66
Efficiency Ratios
Asset Turnover0.390.440.370.110.16
Inventory Turnover2.112.89
Yield & Distribution Ratios
Earnings Yield-0.03%-0.02%-0.02%-0.12%
FCF Yield0.01%0.00%-0.02%-0.10%
Buyback Yield-0.02%-0.07%-0.08%-0.60%-0.19%